| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals International, Plc (KNSA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. KNSA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 137.2K | $7.81M | - | |
| Dir | 64.5K | $3.67M | - | |
| CEO | 60.0K | $3.42M | - | |
| Other | 38.9K | $2.21M | - | |
| CFO | 38.4K | $2.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Ragosa Mark | Chief Financial Officer | Sale+OE | 36,722 | $45.92 | $1,686,157.82 | -46.1% | - | - | |
| Feb 12, 2026 | Quart Barry D56 | Director | Sale+OE | 2,800 | $45.00 | $126,000.00 | -10.0% | - | - | |
| Feb 4, 2026 | Quart Barry D56 | Director | Sale+OE | 15,960 | $45.22 | $721,634.60 | -29.8% | +27.0% | - | |
| Jan 8, 2026 | Ragosa Mark | Chief Financial Officer | Sell | 12,000 | $41.89 | $502,680.00 | -38.6% | +12.7% | - | |
| Dec 15, 2025 | Quart Barry D56 | Director | Sale+OE | 20,129 | $41.51 | $835,554.79 | -61.6% | +11.9% | - | |
| Dec 15, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 12,048 | $41.56 | $500,714.88 | -42.0% | +11.9% | - | |
| Dec 8, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 42,841 | $41.49 | $1,777,473.09 | -58.0% | +12.6% | - | |
| Nov 26, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 200 | $42.89 | $8,578.00 | -0.9% | +2.3% | - | |
| Nov 17, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 12,470 | $41.24 | $514,224.10 | -17.9% | +9.6% | - | |
| Nov 12, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 19,900 | $40.94 | $814,706.00 | -39.0% | +10.2% | - |